View Full Version : New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month

03-12-2011, 03:11 AM
The Food and Drug Administration (FDA) approved BenlystaŽ (belimumab), a new biologic therapy developed to treat patients suffering from active, autoantibody-positive systemic lupus erythematosus (SLE). This landmark decision heralds the first new therapy developed and approved by the FDA specifically for lupus since 1955. According to Virginia T...

More... (http://www.medicalnewstoday.com/articles/218990.php)